ALBANY, N.Y., Aug. 25, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, will present at the Stifel Nicolaus Healthcare Conference on Thursday, September 8, 2011, at 3:15 p.m. ET. Joseph Gersuk, Executive Vice President and Chief Financial Officer of AngioDynamics, will review the Company's business strategy and recent corporate developments.
A live webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's Web site at http://investors.angiodynamics.com under "Events & Presentations."
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.AngioDynamics.com.
CONTACT: AngioDynamics, Inc.D. Joseph Gersuk, CFO
(800) 772-6446 x1608
jgersuk@AngioDynamics.com
Investor Relations Contacts:
EVC Group, Inc.Doug Sherk/ Greg Gin
(415) 568-4887; (646) 445-4801
dsherk@evcgroup.com;
ggin@evcgroup.com
Media Contact:
EVC Group, Inc.Steve DiMattia
(646) 201-5445
sdimattia@evcgroup.com
Source:
AngioDynamics
News Provided by Acquire Media